Wall Street Zen lowered shares of Eupraxia Pharmaceuticals (NASDAQ:EPRX – Free Report) from a hold rating to a sell rating in a research note published on Sunday morning. Several other equities analysts also recently issued reports on the stock. HC Wainwright restated a “buy” rating and set a $12.00 price objective on shares of Eupraxia […]

Wall Street Zen lowered shares of Neuphoria Therapeutics (NASDAQ:NEUP – Free Report) from a hold rating to a sell rating in a report released on Sunday morning. NEUP has been the topic of a number of other research reports. HC Wainwright restated a “buy” rating and set a $21.00 target price on shares of Neuphoria […]

Ocular Therapeutix (NASDAQ:OCUL – Get Free Report) was upgraded by research analysts at Wall Street Zen from a “sell” rating to a “hold” rating in a research report issued to clients and investors on Monday. A number of other equities research analysts also recently weighed in on OCUL. Cowen reaffirmed a “buy” rating on shares […]

Wall Street Zen lowered shares of Coda Octopus Group (NASDAQ:CODA – Free Report) from a buy rating to a hold rating in a research note published on Sunday. Separately, Weiss Ratings reissued a “hold (c)” rating on shares of Coda Octopus Group in a report on Monday, November 17th. One analyst has rated the stock […]